The latest closing stock price for Avalo Therapeutics as of February 21, 2025 is 8.44.
An investor who bought $1,000 worth of Avalo Therapeutics stock at the IPO in 2015 would have $-999 today, roughly -1 times their original investment - a -55.16% compound annual growth rate over 9 years.
The all-time high Avalo Therapeutics stock closing price was 20793.60 on February 27, 2019.
The Avalo Therapeutics 52-week high stock price is 34.46, which is 308.3% above the current share price.
The Avalo Therapeutics 52-week low stock price is 4.24, which is 49.8% below the current share price.
The average Avalo Therapeutics stock price for the last 52 weeks is 10.24.
An investor who bought $1,000 worth of Avalo Therapeutics stock at the IPO in 2015 would have $-999 today, roughly -1 times their original investment - a -55.16% compound annual growth rate over 9 years.
The all-time high Avalo Therapeutics stock closing price was 20793.60 on February 27, 2019.
The Avalo Therapeutics 52-week high stock price is 34.46, which is 308.3% above the current share price.
The Avalo Therapeutics 52-week low stock price is 4.24, which is 49.8% below the current share price.
The average Avalo Therapeutics stock price for the last 52 weeks is 10.24.